» Articles » PMID: 38226507

A Physical Activity and Diet Just-in-Time Adaptive Intervention to Reduce Blood Pressure: The MyBPmyLife Study Rationale and Design

Abstract

Background: Smartphone applications and wearable devices are promising mobile health interventions for hypertension self-management. However, most mobile health interventions fail to use contextual data, potentially diminishing their impact. The myBPmyLife Study is a just-in-time adaptive intervention designed to promote personalized self-management for patients with hypertension.

Methods And Results: The study is a 6-month prospective, randomized-controlled, remotely administered trial. Participants were recruited from the University of Michigan Health in Ann Arbor, Michigan or the Hamilton Community Health Network, a federally qualified health center network in Flint, Michigan. Participants were randomized to a mobile application with a just-in-time adaptive intervention promoting physical activity and lower-sodium food choices as well as weekly goal setting or usual care. The mobile study application encourages goal attainment through a central visualization displaying participants' progress toward their goals for physical activity and lower-sodium food choices. Participants in both groups are followed for up for 6 months with a primary end point of change in systolic blood pressure. Exploratory analyses will examine the impact of notifications on step count and self-reported lower-sodium food choices. The study launched on December 9, 2021, with 484 participants enrolled as of March 31, 2023. Enrollment of participants was completed on July 3, 2023. After 6 months of follow-up, it is expected that results will be available in the spring of 2024.

Conclusions: The myBPmyLife study is an innovative mobile health trial designed to evaluate the effects of a just-in-time adaptive intervention focused on improving physical activity and dietary sodium intake on blood pressure in diverse patients with hypertension.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05154929.

References
1.
Chandrasekaran R, Katthula V, Moustakas E . Patterns of Use and Key Predictors for the Use of Wearable Health Care Devices by US Adults: Insights from a National Survey. J Med Internet Res. 2020; 22(10):e22443. PMC: 7600024. DOI: 10.2196/22443. View

2.
Brewer L, Jenkins S, Hayes S, Kumbamu A, Jones C, Burke L . Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial. Am Heart J. 2022; 247:1-14. PMC: 9037298. DOI: 10.1016/j.ahj.2022.01.009. View

3.
Krebs P, Duncan D . Health App Use Among US Mobile Phone Owners: A National Survey. JMIR Mhealth Uhealth. 2015; 3(4):e101. PMC: 4704953. DOI: 10.2196/mhealth.4924. View

4.
Spruijt-Metz D, Marlin B, Pavel M, Rivera D, Hekler E, De La Torre S . Advancing Behavioral Intervention and Theory Development for Mobile Health: The HeartSteps II Protocol. Int J Environ Res Public Health. 2022; 19(4). PMC: 8872509. DOI: 10.3390/ijerph19042267. View

5.
Iwane M, Arita M, Tomimoto S, Satani O, Matsumoto M, Miyashita K . Walking 10,000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertens Res. 2000; 23(6):573-80. DOI: 10.1291/hypres.23.573. View